ID   1A3.1.1
AC   CVCL_U720
SY   anti-FcRH4-1A3
DR   ATCC; PTA-6339
DR   Wikidata; Q54582651
RX   Patent=US7888478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6339.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96PJ5; Human FCRL4/CD307d.
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 23-09-21; Version: 4
RX   Patent=US7888478;
RA   Chang W., de Sauvage F.J., Eaton D.L., Ebens A.J. Jr., Frantz G.D.,
RA   Hongo J.-A.S., Koeppen H., Polson A., Smith V.;
RT   "Compositions and methods for the treatment of tumor of hematopoietic
RT   origin.";
RL   Patent number US7888478, 15-Feb-2011.